BlackRock Portfolio holdings
AUM
$5.23T
1-Year Return
24.48%
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
This Quarter Return
-3.54%
1 Year Return
+24.48%
3 Year Return
+103%
5 Year Return
+187.44%
10 Year Return
+430.33%
AUM
$2.93T
AUM Growth
-$181B
(-5.8%)
Cap. Flow
-$23.8B
Cap. Flow
% of AUM
-0.81%
Top 10 Holdings %
Top 10 Hldgs %
19.42%
Holding
5,969
New
125
Increased
2,136
Reduced
2,859
Closed
169
Top Buys
| 1 |
Tesla
TSLA
|
+$1.53B |
| 2 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$778M |
| 3 |
CoStar Group
CSGP
|
+$590M |
| 4 |
Healthcare Realty
HR
|
+$587M |
| 5 |
Rivian
RIVN
|
+$473M |
Top Sells
| 1 |
Apple
AAPL
|
+$1.17B |
| 2 |
CDK
CDK Global, Inc.
CDK
|
+$1.02B |
| 3 |
ACC
American Campus Communities, Inc.
ACC
|
+$1.01B |
| 4 |
Chevron
CVX
|
+$980M |
| 5 |
Johnson & Johnson
JNJ
|
+$900M |
Sector Composition
| 1 | Technology | 22.17% |
| 2 | Healthcare | 15.33% |
| 3 | Financials | 12.53% |
| 4 | Consumer Discretionary | 10.4% |
| 5 | Industrials | 8.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
4676
KALA BIO
KALA
$131M
| $175K | ﹤0.01% |
15,745
-140
| -0.9% | -$1.56K |
|
|
ACCS
4677
ACCESS Newswire Inc.
ACCS
$40.3M
| $174K | ﹤0.01% |
8,575
-138
| -2% | -$2.8K |
|
4678
Blackstone Secured Lending
BXSL
$6.58B
| $172K | ﹤0.01% |
7,582
+567
| +8% | +$12.9K |
|
|
EAD
4679
Allspring Income Opportunities Fund
EAD
$419M
| $172K | ﹤0.01% |
27,761
-49,589
| -64% | -$307K |
|
4680
Zedge
ZDGE
$41.8M
| $172K | ﹤0.01% |
72,575
-984
| -1% | -$2.33K |
|
|
AVDL
4681
Avadel Pharmaceuticals
AVDL
$1.5B
| $171K | ﹤0.01% |
34,069
+5,299
| +18% | +$26.6K |
|
|
RDHL
4682
Redhill Biopharma
RDHL
$3.47M
| $171K | ﹤0.01% |
339
-18
| -5% | -$9.08K |
|
4683
Surrozen
SRZN
$99.2M
| $171K | ﹤0.01% |
5,642
-967
| -15% | -$29.3K |
|
|
ORGS
4684
DELISTED
Orgenesis Inc. Common Stock
ORGS
| $171K | ﹤0.01% |
12,045
-163
| -1% | -$2.31K |
|
4685
Ark Restaurants
ARKR
$25M
| $170K | ﹤0.01% |
9,145
+165
| +2% | +$3.07K |
|
4686
Canterbury Park Holding Corp
CPHC
$83.6M
| $170K | ﹤0.01% |
7,595
+102
| +1% | +$2.28K |
|
4687
Kingsway Financial Services
KFS
$414M
| $170K | ﹤0.01% |
24,557
-10,501
| -30% | -$72.7K |
|
|
HGEN
4688
DELISTED
HUMANIGEN, INC.
HGEN
| $170K | ﹤0.01% |
945,438
-4,156
| -0.4% | -$747 |
|
4689
Abeona Therapeutics
ABEO
$330M
| $169K | ﹤0.01% |
55,728
-36
| -0.1% | -$109 |
|
4690
First US Bancshares
FUSB
$69.1M
| $169K | ﹤0.01% |
21,333
-439
| -2% | -$3.48K |
|
4691
Limbach Holdings
LMB
$1.23B
| $169K | ﹤0.01% |
22,218
-7,298
| -25% | -$55.5K |
|
4692
Jasper Therapeutics
JSPR
$39.5M
| $168K | ﹤0.01% |
21,303
-504
| -2% | -$3.98K |
|
4693
Pathfinder Bancorp
PBHC
$92.4M
| $168K | ﹤0.01% |
8,309
-105
| -1% | -$2.12K |
|
|
TBIO
4694
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
| $166K | ﹤0.01% |
5,565
-119
| -2% | -$3.55K |
|
|
ACER
4695
DELISTED
Acer Therapeutics Inc. Common Stock (DE)
ACER
| $166K | ﹤0.01% |
118,826
-1,279
| -1% | -$1.79K |
|
|
VIVE
4696
DELISTED
VIVEVE MED INC
VIVE
| $166K | ﹤0.01% |
244,226
| – | – |
|
|
OPRA
4697
Opera Ltd
OPRA
$1.76B
| $165K | ﹤0.01% |
37,936
+14,406
| +61% | +$62.7K |
|
4698
Tonix Pharmaceuticals
TNXP
$251M
| $165K | ﹤0.01% |
15
-2
| -12% | -$22K |
|
4699
Vanguard Information Technology ETF
VGT
$103B
| $164K | ﹤0.01% |
532
+380
| +250% | +$117K |
|
|
MIRO
4700
DELISTED
Miromatrix Medical Inc. Common Stock
MIRO
| $164K | ﹤0.01% |
37,622
+2,544
| +7% | +$11.1K |
|